Global Antibiotics Market 2014-2018

2014-09-17
Price :
Published : Sep-2014
No. of Pages : 96

Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term “antibiotic” is often used synonymously with antibacterial; however, the term “antibiotic” was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. It can be bacteriostatic or bactericidal in nature. Antibiotics are medicines that are used to treat infections caused by bacteria (e.g., respiratory tract infections). Antibiotics work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. Antibiotics either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).

TechNavio’s analysts forecast the Global Antibiotics market to grow at a CAGR of 1.41 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Antibiotics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various antibiotics for human use. The Global Antibiotics market can be divided into eight segments: Beta-lactams, Macrolides, Aminoglycosides, Phenicols, Quinolones, Sulfonamides, Tetracyclines, and Others.

TechNavio’s report, the Global Antibiotics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Antibiotics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • Bayer HealthCare
  • Bristol Myers Squibb
  • Cubist Pharmaceuticals
  • Daiichi Sankyo
  • F. Hoffmann-La Roche
  • Takeda Pharmaceutical

Market Driver

  • Increased Aging Population
  • For a full, detailed list, view our report

Market Challenge

  • Emergence of Drug-resistant Strains
  • For a full, detailed list, view our report

Market Trend

  • Increase in Demand for Antibiotics
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2018. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides......
$1000

Peanut Allergy: Epidemiology Forecast to 2027

Peanut Allergy: Epidemiology Forecast to 2027 Summary Peanut allergy is a type of food allergy in which the individual is allergic to peanut, which is part of the legume family. Peanut allergy is an immunoglobulin E (IgE) mediated type-I hypersensitivity reaction in which, once exposed to peanut, the body elicits an inappropriate immune response, causing the symptomology seen in allergic persons. The minimum dose of exposure to elicit an allergic response is highly variable, with some people only requiring trace amounts for a severe reaction. GlobalData epidemiologists provide a 10-year epidemiological forecast for the probable diagnosed prevalent cases of peanut allergy by age and sex, as well as the probable diagnosed prevalent cases of peanut allergy with associated comorbidity, and ......
$3995

Peritoneal Cancer Global Clinical Trials Review, H1, 2018

Peritoneal Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Peritoneal Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Peritonitis Global Clinical Trials Review, H1, 2018

Peritonitis Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Peritonitis Global Clinical Trials Review, H1, 2018" provides an overview of Peritonitis clinical trials scenario. This report provides top line data relating to the clinical trials on Peritonitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Periventricular Leukomalacia Global Clinical Trials Review, H1, 2018

Periventricular Leukomalacia Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Periventricular Leukomalacia Global Clinical Trials Review, H1, 2018" provides an overview of Periventricular Leukomalacia clinical trials scenario. This report provides top line data relating to the clinical trials on Periventricular Leukomalacia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary......
$2500

Peyronies Disease Global Clinical Trials Review, H1, 2018

Peyronies Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Peyronies Disease Global Clinical Trials Review, H1, 2018" provides an overview of Peyronies Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Peyronies Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Dysmenorrhea Global Clinical Trials Review, H1, 2018

Dysmenorrhea Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Dysmenorrhea Global Clinical Trials Review, H1, 2018" provides an overview of Dysmenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Dysmenorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2018

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2018" provides an overview of Pharyngeal Neoplasm clinical trials scenario. This report provides top line data relating to the clinical trials on Pharyngeal Neoplasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Hyperthyroidism Global Clinical Trials Review, H1, 2018

Hyperthyroidism Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Hyperthyroidism Global Clinical Trials Review, H1, 2018" provides an overview of Hyperthyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018" provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report provides top line data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy